65PDHigh tumor mutational burden (TMB) and PD-L1 have...

Annals of Oncology 2018 / 10 Vol. 29; Iss. suppl_8

65PDHigh tumor mutational burden (TMB) and PD-L1 have similar predictive utility in 2L+ NSCLC patients (pts) treated with anti-PD-L1 and anti-CTLA-4

Higgs, B W, Morehouse, C A, Brohawn, P Z, Sridhar, S, Raja, R, Gao, G, Englert, J, Ranade, K
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
29
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdy269.063
Date:
October, 2018
File:
PDF, 76 KB
english, 2018
Conversion to is in progress
Conversion to is failed